COVID-19: Current Challenges and Future Perspectives

On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 presents significant challenges to health systems and public health in both hemispheres as well as to the economies of each...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (264 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05455nam-a2201465z--4500
001 993545019604498
005 20240823172022.0
006 m o d
007 cr|mn|---annan
008 202205s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5680000000037689 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/81066 
035 |a (EXLCZ)995680000000037689 
041 0 |a eng 
100 1 |a Leggat, Peter  |4 edt 
245 1 0 |a COVID-19: Current Challenges and Future Perspectives 
246 |a COVID-19 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (264 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 |a Open access  |f Unrestricted online access  |2 star 
520 |a On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 presents significant challenges to health systems and public health in both hemispheres as well as to the economies of each country. The morbidity and mortality due to infections caused by SARS-CoV-2 have been significant despite the short duration since its discovery and initially overwhelmed many hospitals and clinics. It influences everyone, and countermeasures have been dramatic in their impact on employment, social systems, and mental health. This Special Issue provides an avenue for authors from various disciplines to provide feedback on our responses and preparedness to COVID-19 globally as well as to disseminate critical information about the SARS-CoV-2 virus and the associated COVID-19 pandemic. It consists of 22 peer-reviewed papers that cover worldwide perspectives encompasses the following: Original articles about COVID-19 (including epidemiology, modelling, clinical data, treatment, prevention, countermeasures, impacts on tropical regions, response, and preparedness);Original articles about SARS-CoV-2 (microbiology, virology, transmission, pathology, and vaccinology);Perspectives about COVID-19 and SARS-CoV-2 (comparisons with past coronavirus outbreaks, impactful local initiatives, novel responses, and commentaries);Reviews on COVID-19 (based on systematic and narrative reviews);and Innovations (vaccine development, drug trials, and original countermeasures). 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Environmental medicine  |2 bicssc 
653 |a COVID-19 
653 |a SARS-CoV-2 
653 |a hepatitis B and C 
653 |a cirrhosis 
653 |a chronic kidney disease 
653 |a alcohol-related liver disease 
653 |a nonalcoholic steatohepatitis 
653 |a necrosis 
653 |a MDR-TB 
653 |a clinical trials 
653 |a IL-6 inhibitors 
653 |a tocilizumab 
653 |a cytokine release syndrome 
653 |a cytokine storm 
653 |a operational research 
653 |a health systems 
653 |a SORT IT 
653 |a pandemics 
653 |a training 
653 |a pandemic 
653 |a endemic 
653 |a tuberculosis 
653 |a impact 
653 |a control 
653 |a overview 
653 |a malaria 
653 |a preparedness 
653 |a Africa 
653 |a emergency 
653 |a fecal calprotectin 
653 |a bowel perforation 
653 |a D-Dimer 
653 |a thrombosis 
653 |a ischemia 
653 |a efficacy 
653 |a safety 
653 |a kaletra 
653 |a lopinavir/ritonavir 
653 |a meta-analysis 
653 |a coronavirus 
653 |a SARS-CoV-1 
653 |a MERS 
653 |a SARS 
653 |a influenza 
653 |a healthcare worker 
653 |a healthcare personnel 
653 |a general practitioners 
653 |a medical doctor 
653 |a heart transplant 
653 |a CMV 
653 |a Chagas disease 
653 |a infection 
653 |a severity 
653 |a respiratory viruses 
653 |a coinfections 
653 |a health care workers 
653 |a Philippines 
653 |a rhinovirus 
653 |a severe acute respiratory syndrome coronavirus 2 
653 |a plasmodium falciparum 
653 |a differential diagnosis 
653 |a cognitive bias 
653 |a diagnostic reasoning 
653 |a recurrence 
653 |a reinfection 
653 |a Bangladesh 
653 |a Kenya 
653 |a Nairobi 
653 |a presumptive tuberculosis 
653 |a TB treatment outcomes 
653 |a HIV 
653 |a antiretroviral therapy 
653 |a EpiCollect5 
653 |a Malawi 
653 |a Lilongwe 
653 |a Zimbabwe 
653 |a Harare 
653 |a real-time operational research 
653 |a ethics 
653 |a research capacity building 
653 |a India 
653 |a Nepal 
653 |a post-acute COVID-19 syndrome 
653 |a COVID-19 vaccines 
653 |a mortality 
653 |a epidemiology 
653 |a public health 
653 |a healthcare workers 
653 |a attitudes 
653 |a perceptions 
653 |a knowledge 
776 |z 3-0365-3118-1 
776 |z 3-0365-3119-X 
700 1 |a Frean, John  |4 edt 
700 1 |a Blumberg, Lucille  |4 edt 
700 1 |a Leggat, Peter  |4 oth 
700 1 |a Frean, John  |4 oth 
700 1 |a Blumberg, Lucille  |4 oth 
906 |a BOOK 
ADM |b 2024-08-24 02:29:53 Europe/Vienna  |f system  |c marc21  |a 2022-05-14 21:41:54 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337828440004498&Force_direct=true  |Z 5337828440004498  |b Available  |8 5337828440004498